 - Patients of childbearing or child fathering potential must be willing to use an acceptable method of birth control prior to study entry and for the duration of the study; acceptable methods of contraception include hormonal, barrier methods, intrauterine device, tubal ligationvasectomy or abstinence; women should not breast feed while on treatment with sunitinib and HCQ 